Average Co-Inventor Count = 3.19
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Curna, Inc. (26 from 111 patents)
2. The Scripps Research Institute (1 from 1,189 patents)
3. Opko Curna, LLC (1 patent)
26 patents:
1. 11408004 - Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
2. 11390868 - Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
3. 10995334 - Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
4. 10793857 - Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
5. 10604755 - Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
6. 10519448 - Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
7. 10465192 - Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
8. 10435690 - Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
9. 10214745 - Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
10. 10113166 - Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
11. 9902958 - Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
12. 9873873 - Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
13. 9834769 - Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
14. 9771579 - Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
15. 9725756 - Treatment of 'C terminus of HSP7O-interacting protein' (CHIP) related diseases by inhibition of natural antisense transcript to CHIP